Clinical trial
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
NCT00403533 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00403533 |
|---|---|
| Title | Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus |
| Official title | Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | 20 mg of atorvastatin daily |
| Enrollment | 10 |
| Start date | Feb 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Nov 23, 2006 |
| Last update posted | Nov 23, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: